Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms influencing antihypertensive drug responses

3 Dec 2024

Abstract excerpt

Hypertension is a major contributor to cardiovascular disease and its associated morbidity and mortality. The low efficacy observed with some anti-hypertensive therapies has been attributed partly to inter-individual genetic variability. This paper reviews the major findings regarding these genetic variabilities that modulate responses to anti-hypertensive therapies such as angiotensin converting enzyme (ACE)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hormonal Regulation and Hypertension
Share to Pharmacogenetics and Drug Metabolism
Share to Receptor Mechanisms and Signaling

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39627167
DOI: 10.1111/bph.17414

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms influencing antihypertensive drug responsesPMID 39627167Read ↗

Pharmacogenetics of antihypertensive treatment.Semantic proximity Read ↗

Pharmacogenetics of antihypertensive drug response.Semantic proximity Read ↗

[Individual sensitivity to antihypertensive drugs: genetic aspects].Semantic proximity Read ↗

Pharmacogenomics And Hypertension: Current InsightsSemantic proximity Read ↗

Pharmacogenomics in Hypertension: Where We Stand TodaySemantic proximity Read ↗

Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseasesSemantic proximity Read ↗

Genetics, ancestry, and hypertension: implications for targeted antihypertensive therapies.Semantic proximity Read ↗

Exploring the Role of Genetic and Genomic Factors in Therapeutic Response to Heart Failure: A Comprehensive Analytical ReviewSemantic proximity Read ↗

Cardiovascular pharmacogenomics.Semantic proximity Read ↗

Pharmacogenomic approaches to study the effects of antihypertensive drugs.Semantic proximity Read ↗

Gene-environment interactions of selected pharmacogenes in arterial hypertension.Semantic proximity Read ↗

Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.